Self-driving cars are sold as a safety story. For a large group of Americans, they are something more practical: a path back to independence. When the vehicle—not the driver—handles steering, braking, and traffic, people who can still live alone, manage a household, and think clearly may travel again without asking someone else for a ride. That is the promise. The hard part is deciding who gets that independence, and what responsibility looks like when a human is no longer operating the car.

In a spine clinic, that question is concrete. I see patients whose feet and legs no longer negotiate the brake pedal the way they used to. The problem is not always “old age.” Often it is neurologic disease that steals the precise strength and sensation driving demands. The same automation debate already sits in the operating room: technology can extend what a person can do , but it does not erase judgment, design, or who answers when something goes wrong.

Spine Problems Can Stop Patients From Driving

Radiculopathy is compression of a spinal nerve root—classically from a disc herniation or degenerative change—sending pain, numbness, or weakness into an arm or leg along that nerve’s territory. Peripheral neuropathy is damage to nerves outside the brain and spinal cord; it commonly causes numbness, pain, and weakness in the feet and hands. Myopathy is disease of the muscle itself, producing weakness that can make climbing stairs, rising from a chair, or sustaining force at the pedals harder. Any one can impair driving. In combination—common in complex spine patients—they can make safe control of acceleration and braking unreliable even when cognition is intact.

That distinction matters. Many of these patients have a graduated level of functional independence at home: they dress, cook, manage meds, and think clearly. What they lack is reliable transportation independence. The car is still the bridge to care, work, worship, and family in much of America. It’s even difficult to get to doctor appointments. When transportation is difficult, the rest of independence frays—and automation’s value is restoring that bridge without pretending the disease went away.

What Losing The Keys Actually Costs Patients

Classic public-health work estimated that more than 600,000 Americans age 70 and older stop driving each year and become dependent on others for transportation. The National Institute on Aging notes that giving up the keys often feels like giving up freedom of movement, with real worry about isolation as errands and social life shrink. In a longitudinal study of community-dwelling older adults, driving cessation was associated with a precipitous drop in “life-space”—how far people move through their communities— roughly 28 points on a standard life-space score at the time of stopping, after adjustment. The body may still support a meaningful life; geography collapses to whoever can drive you.

Where Self-Driving Cars Can Help Patients

NHTSA has said that vehicles with higher levels of automation could offer new mobility options to older Americans and people with disabilities, helping them live more independently or reconnect to jobs and care. That is the clinical upside: a patient who cannot safely modulate pedals might still travel if the vehicle—not the diseased foot—handles the dynamic driving task inside a defined service area.

Honesty requires the hedge. NHTSA also emphasizes that fully automated cars are not something you can simply buy for unsupervised use everywhere; much of what consumers see still demands an attentive human. Driverless robotaxi service exists only in limited cities and conditions. Accessibility is not automatic—design, cost, and interfaces will decide whether the technology serves patients who need it most.

Then comes responsibility. If the machine is driving, does personal responsibility shrink? For a spine patient who simply cannot work pedals safely, shifting the driving task looks less like abdication and more like matching technology to disability—the same logic as hand controls or maybe even a designated driver. There are similar corollaries in other industries . The harder question perhaps is how should society view or treat the intoxicated or otherwise inebriated driver of a self-driving car. Is that ok?

Companies operating driverless rides generally treat the rider as a passenger and say they accept crash liability when the system is in control—yet the legal line between “passenger” and “operator” is still being stress-tested. Reporting on robotaxis has flagged unsettled liability questions around intoxicated passengers. Separately, a major robotaxi operator’s rules prohibit consuming alcohol or drugs inside the vehicle . NHTSA notes that liability and insurance questions remain for policymakers as automation matures.

Are we “OK” with a drunk person summoning a driverless car? Reasonable people split. One view: if no impaired human is operating the vehicle, society may prefer that person inside a supervised autonomous ride rather than behind a wheel. The opposing view: automation should not become a loophole that normalizes intoxication, blurs accountability, or transfers risk onto everyone else while the law catches up.

Self-Driving Cars And Clinical Medicine

Spine disease, neuropathy, and myopathy do not erase a person’s need to get to treatment, church, or a grandchild’s game. For selected patients, higher-level automation—where it is actually available and appropriately designed—could be the difference between functional independence that stops at the driveway and a life that still reaches the world. That potential is dramatic. How we expand it, regulate the edge cases, and keep responsibility clear is a public choice.